Cabaletta Bio (CABA) Short-term Investments (2020 - 2025)
Cabaletta Bio (CABA) recorded quarterly Short-term Investments of $50.6 million in Q4 2025, down 49.24% quarter-over-quarter from $99.7 million in Q3 2025.
Cabaletta Bio (CABA) Short-term Investments (2020 - 2025) Analysis & Trends
Cabaletta Bio's Short-term Investments history runs 6 years deep, the most recent figure standing at $50.6 million for Q4 2025.
- In Q4 2025, Short-term Investments changed N/A year-over-year to $50.6 million; the TTM figure through Dec 2025 stood at $50.6 million (changed N/A YoY), while the FY2025 annual figure was $50.6 million, changed N/A from the prior year.
- Short-term Investments was $50.6 million for Q4 2025 at Cabaletta Bio, down from $99.7 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $99.7 million in Q3 2025 to a low of $1.0 million in Q3 2021.
- Historically, Short-term Investments has averaged $36.8 million across 5 years, with a median of $48.1 million in 2023.
- The sharpest annual moves came in 2021 and 2022: Short-term Investments sank 87.6% in 2021, then surged 2373.2% in 2022.
- A 5-year view of Short-term Investments shows it stood at $1.0 million in 2021, then soared by 2394.0% to $24.9 million in 2022, then surged by 92.51% to $48.0 million in 2023, then tumbled by 74.16% to $12.4 million in 2024, then surged by 308.07% to $50.6 million in 2025.
- The last three Short-term Investments figures came in at $50.6 million (Q4 2025), $99.7 million (Q3 2025), and $49.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cabaletta Bio | 151.84 Mn | 18.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 50.62 Mn |
| Sep 30, 2025 | 99.73 Mn |
| Jun 30, 2025 | 49.07 Mn |
| Sep 30, 2024 | 12.40 Mn |
| Jun 30, 2024 | 24.61 Mn |
| Mar 31, 2024 | 48.55 Mn |
| Dec 31, 2023 | 48.01 Mn |
| Sep 30, 2023 | 48.89 Mn |
| Jun 30, 2023 | 48.26 Mn |
| Dec 31, 2022 | 24.94 Mn |
| Sep 30, 2022 | 24.73 Mn |
| Jun 30, 2022 | 49.64 Mn |
| Mar 31, 2022 | 49.66 Mn |
| Sep 30, 2021 | 1.00 Mn |
| Jun 30, 2021 | 3.31 Mn |
| Mar 31, 2021 | 4.75 Mn |
| Dec 31, 2020 | 7.23 Mn |
| Sep 30, 2020 | 8.06 Mn |
| Jun 30, 2020 | 7.70 Mn |